Welcome to the European HIV Clinical Forum website!
The 3rd European HIV Clinical Forum on Integrase Inhibitors will be held on 24 October, 2017 in Milan, Italy, just prior to EACS 2017.
This program is an abstract-driven scientific & educational program dedicated to the integration of science and clinical practice focusing on integrase inhibitors.
By joining us, you will be updated on the latest developments related to integrase inhibitors, and will be provided with a platform to share your clinical experience. The program will include plenary lectures, Q&A and debate, stimulating interaction in order to bridge the knowledge gap between experts and the HIV-treatment community.
This Forum offers a unique platform for discussion on the clinical utility of integrase inhibitors in daily practice. After your participation in the meeting, you will be able to:
identify and manage patients who would be eligible for induction-maintenance therapy
recognize potential drug interactions and, based on this knowledge, develop treatment strategies that could prevent these interactions
design treatment strategies for different patient populations
describe and identify the various factors that influence the use of long acting antivirals
Who should attend?
If you are doing research on or have clinical experience with integrase inhibitors or if you are interested in learning more about using integrase inhibitors in daily practice, please join us on 24 October, 2017 in Milan, Italy. Location: Grand Visconti Palace.
We look forward to welcoming you to the meeting in Milan, Italy!
The Program Chairs,
Charles Boucher, MD, PhD
Jonathan Schapiro, MD
Andrzej Horban, MD, PhD
More Scientific Committee members will be confirmed shortly!
24 October 2017
|8.45h||Welcome, Introductions and Goals
Erasmus Medical Center, Rotterdam, The Netherlands
|9.00h||State of the ART: Integrase Inhibitors Resistance
Erasmus Medical Center, Rotterdam, The Netherlands
|9.30h||State of the ART: Integrase Inhibitors (clinical overview)
Sheba Medical Center, Israel
| Changing paradigm: Is reducing drug regimen an option?
|11.00h||What is the virological support to reduce drug regimens?|
|11.30h||What are the clinical outcome data?|
|12.00h||Can we use HIV reservoir assays to predict VF in simplification strategies
Ghent University Hospital
| Real-life data presentations
University of Modena and Reggio Emilia, Italy
|14.30h||Abstract driven presentations|
Pomeranian Medical University, Poland
| Changing paradigm: ARV drugs versus immunotherapy
|16.30h||One pill a day ?: Integration novel delivery systems into routine care
Giovanni Di Perri
University of Turin, Italy
|17.00h||Prospects of immunotherapy for treatment
Case Western Reserve University
| Networking Dinner
Don’t miss out and register for the exciting 3rd European HIV Clinical Forum meeting in Milan, Italy!
Registration is free of charge for Healthcare Practitioners.
| Registration fees
|Healthcare practitioners*||Free registration|
|Early (24 July – 27 August 2017)||EUR 150|
|Full (28 August – 20 October)||EUR 395|
|Onsite (From 21 October on)||EUR 495|
| Non- Sponsoring Industry
|Early (24 July – 27 August 2017)||EUR 695|
|Full (28 August – 20 October)||EUR 895|
|Onsite (from 21 October on)||EUR 995|
| Sponsoring Industry
|10 free registration slots|
|Additional registrations||EUR 595|
*Healthcare practitioners are defined as professionals that provide any type of health care service to HIV-infected patients. If you are not sure, please do not hesitate to contact the Conference Secretariat.
**Non-HCPs are defined as individuals not providing any healthcare service to patients or are part of a commercial pharma company
***Industry is defined as representatives of a commercial institute that do not financially support this workshop (you can find an overview of the workshop sponsors on the workshop website).
***Sponsoring Industry is defined as representatives of a commercial institute that financially support this workshop (you can find an overview of the workshop sponsors on the workshop website).
Registration does not include accommodation and/or travel. Should you require accommodation, please contact the Conference Secretariat at firstname.lastname@example.org.
Conference Participation Grants are available for healthcare practitioners from Europe. Please click on the Grants tab to find out more.
REGISTRATION IS LIMITED!
– We strongly suggest that you register early to ensure your spot at the meeting, as registration will no longer be possible when the capacity of the venue is reached.
– Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when a confirmation of your registration has been sent.
Abstracts should contain the following four components (please bold the four section headings noted below within the text of your abstract submission):
Background: a concise statement of the issue under investigation or a hypothesis;
Materials & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as “to be completed” or “to be presented” are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as “the results will be discussed” are not acceptable).
Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially.
Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
Abstract submission & deadline
Authors can submit their abstracts electronically until 15 September 2017 using the “Submit abstract” button at the bottom of this page. This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.
We encourage you to submit your abstracts on the following topics:
– Basic Virology
– Pharmacology and Drug interactions
– Adverse Events and Toxicity
– Clinical Trials
– Informative case reports
Notification of abstract acceptance and presentation format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to submitting authors before 1 October 2017. It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status.
Please notify the Conference Secretariat if you have not received notification by the first week of October.
If an abstract is accepted, one author is required to register for the conference and present the paper as scheduled.
Abstract Submitter’s Registration Guidelines will be sent together with the notification. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.
Accepted abstracts will be published in the Conference Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal “Reviews in Antiviral Therapy & Infectious Diseases”. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.
Abstract submission deadline: Friday 15 September 2017
Conference Participation Grants
Virology Education (VE), with generous support by ViiV Healthcare, is offering Conference Participation Grants (CPGs) for the 3rd European HIV Clinical Forum in Milan, Italy on 24 October 2017, to HIV Healthcare professionals from Europe.
WHAT DOES THE CPG COVER?
- Registration to the Conference, including:
- Support for travel of up to EUR 400
- Hotel accommodation on the conference dates (2 nights on 23-24 October at the meeting venue)
- All arrangements will be made by VE.
- Applicants must attend the entire Conference.
- Applicants will be responsible for all other costs associated with Conference attendance.
- Please see the Conference website for further details about the Conference.
WHAT IS EXPECTED FROM THE GRANT RECIPIENTS?
- Recipient will be onsite at the Conference, attend all sessions and participate actively for the duration of the Conference.
- Recipient will write a brief article about his/her Conference experience (approximately 500 words) for Conference publicity purposes within 3 months of the end of the Conference.
- The applicant must be a Healthcare Professional.
- The applicant must be willing to share his/her experience at the Conference within his network.
- The applicant must be eligible to obtain a visa for travel.
- The applicant must declare that she/he is able and willing to fund all other costs beyond the grant that are involved in attending the Conference, e.g. all other hotel, travel and subsistence expenses NOT covered by the CPG.
- The applicant must declare to take out her/his own insurance policies (for travel, liability, illness and/or other necessary insurances in relation to her/his participation to the Conference).
Your application will include the following:
- Your contact details (e.g. name and email address)
- Motivation letter consisting of a written statement of up to 200 words, on
- how attending the Conference will benefit you in a professional capacity
- how you intend to apply the benefits that you have outlined in a practical way after the Conference
- Recommendation letter(s) (optional)
- Abstract(s) (optional)
- A declaration that you agree with the terms & conditions for application
- Your application must be received by Friday 15 September 2017
- All applications will be acknowledged upon receipt.
- All applications will be reviewed by an independent CPG Review Committee based on the following Grant Selection Criteria:
- Professional background
- Strategy of knowledge dissemination
- Recommendation by the Scientific and Organizing Committee of the meeting
- Quality of the Abstract (if accepted)
- Young/ Early Career Investigator
- All applicants will receive notification of the application status no later than Sunday 1 October 2017.
- Incomplete applications will not be considered.
- Retrospective applications will not be considered.
- Applications will be considered until the exhaustion of funds.
- Applicants will be notified of the decision by email. Successful applicants will be notified with further instructions.
- Conference Participation Grants are non-transferrable.
- The applicant will not hold Virology Education liable for any losses, costs, expenses, causes of action, claims and suits for property damage, theft of property of personal injury (including death) arising in connection with the CGP and participation in the Conference.
- Virology Education cannot be held responsible for any incorrect information that is submitted through the CPG application portal.
- Virology Education reserves the right to make the final decision regarding all applications, which cannot be disputed.
- You are committed to attend the meeting in person. If you fail to do so, you will be charged the full amount of the travel and accommodation costs incurred and will be excluded from applications for future conference participation grants of Virology Education.
Please note that we are having some technical difficulties with our grant portal. If you are unable to upload your application materials, please email Lena Hartandi-Niesen on email@example.com. Thank you for your understanding!
CPG application deadline: Friday 15 September 2017
Corporate Support Opportunities
Financial backing from the corporate community will help us deliver an impactful and essential meeting experience. This collaboration plays a vital role for both the organizational and the scientific success of the program.
Your financial support will help advance the field significantly by providing healthcare professionals with a platform to present findings, discuss conclusions, and create strategies for the future.
Show your commitment to the cause and get in touch with us for a tailored support package. Please contact Alice Posthumus-Plantinga at firstname.lastname@example.org or call +31 6 224 82 179.
The 3rd European HIV Forum meeting : Integrase Inhibitors is generously supported by an unrestricted educational grant from ViiV Healthcare.
The European HIV Clinical Forum is endorsed by the following organizations. Their support and collaboration play a key role to this meeting’s success and we are proud and honoured to call each and every one of them partners. Members of the below organizations receive a 25% discount on registration fees. Get in touch with us if you want your organization to be part of this meeting, at email@example.com.
More information about accreditation coming soon.